Class 2 medicine recall High risk 27 September 2021

Accord-UK Ltd (Trading style: NorthStar), LEVOTHYROXINE TABLETS BP 50 micrograms

Yes – this has been recalled
The problem
Accord-UK Ltd (Trading style: NorthStar) are recalling the above batch of product as a precautionary measure due to tablet hardness failures, leading to crumbling and breaking tablets.
What to do
Check the batch number on your pack against the list below. Do not stop taking a prescribed medicine without talking to your pharmacist, GP or prescriber first – they can check your supply and swap it if needed.
Source: Medicines and Healthcare products Regulatory Agency (MHRA) Official notice ↗

Company name

Accord-UK Ltd (Trading style: NorthStar)

LEVOTHYROXINE TABLETS BP 50 micrograms

Batch number Expiry date Pack size First distributed
XATA30 Jan-2023 28 09 August 2021

Active Pharmaceutical Ingredient: levothyroxine

MDR number

404-09/21

Brief description of the problem

Accord-UK Ltd are recalling the above batch of Levothyroxine Tablets BP 50 micrograms as a precautionary measure due to out of specification results for tablet hardness obtained during stability testing. This issue may result in tablets that crumble or break when removed from the packaging.

Advice for healthcare professionals

Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Further Information

For more information or medical information queries, please contact:
Accord-UK Ltd Medical Information Department on 01271 385257

For stock control queries, please contact:
Accord-UK Ltd Customer Services Team on 0800 373573

Recipients of this Medicines Recall should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

Download document

Class 2 Medicines Recall: Accord-UK Ltd (Trading style: NorthStar), LEVOTHYROXINE TABLETS BP 50 micrograms EL (21)A/23

Updated 27 September 2021. This page summarises an official notice. Details can change – always follow the official notice.

Website built by: www.NocturnalMedia.co.uk